tiprankstipranks
Trending News
More News >
Auna S.A. Class A (AUNA)
NYSE:AUNA
US Market

Auna S.A. Class A (AUNA) AI Stock Analysis

Compare
277 Followers

Top Page

AUNA

Auna S.A. Class A

(NYSE:AUNA)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 5.2)
Rating:58Neutral
Price Target:
$5.50
▲(10.22% Upside)
Action:ReiteratedDate:11/23/25
Auna S.A. Class A's overall stock score is primarily influenced by its stable financial performance and undervaluation, despite technical indicators suggesting a bearish trend. The earnings call highlighted regional strengths but also significant challenges, particularly in Mexico. The lack of corporate events further emphasizes the need for strategic improvements to enhance investor confidence.
Positive Factors
Free Cash Flow Strength
Sustained free cash flow growth indicates durable internal funding for capex, network upgrades and debt reduction. Strong cash conversion supports strategic investments and provides flexibility to absorb cyclical downturns without immediate external financing.
Debt Refinancing
The large refinancing that extends maturities and lowers interest costs materially reduces near-term refinancing risk and interest burden. This structural improvement enhances liquidity and gives management time to execute operational fixes and growth initiatives.
Regional Revenue Diversification
Consistent growth and margin expansion in Peru and Colombia create resilient revenue streams outside Mexico. Geographic diversification lowers concentration risk, stabilizes consolidated cash flow, and provides a platform to fund expansion while Mexico recovers.
Negative Factors
High Leverage
A high debt-to-equity ratio signals elevated financial risk and limits strategic flexibility. Even with refinancing, carry and covenant constraints can restrict investment choices, increase sensitivity to interest rate shocks, and slow deleveraging absent sustained cash generation.
Mexico Operational Issues
Significant revenue and EBITDA declines in Mexico reflect persistent operational problems, slower volume recovery and strained provider relationships. Given Mexico's scale, prolonged underperformance and ERP integration delays risk long recovery timelines and pressure consolidated margins.
Low Net Profit Conversion
A low net margin despite healthy gross margins suggests cost structure and SG&A pressures limiting profitability. The sharp revenue decline erodes operating leverage, reducing self-funding capacity for growth and making sustained margin improvement critical to long-term financial health.

Auna S.A. Class A (AUNA) vs. SPDR S&P 500 ETF (SPY)

Auna S.A. Class A Business Overview & Revenue Model

Company DescriptionAuna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.
How the Company Makes MoneyAuna S.A. generates revenue through multiple channels, primarily by offering subscription-based services for broadband internet, television, and telephony to residential and business clients. The company charges monthly fees for its service packages, which often include bundled offerings to attract customers. Additionally, AUNA earns revenue from advertising on its media platforms and through partnerships with content providers for premium programming. Strategic collaborations with technology firms also enable AUNA to enhance its service capabilities and expand its market reach, contributing to a steady growth in earnings.

Auna S.A. Class A Earnings Call Summary

Earnings Call Date:Nov 20, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 16, 2026
Earnings Call Sentiment Neutral
The earnings call presented a mixed picture with strong performances in Peru and Colombia, successful debt refinancing, and positive developments in Mexico's oncology and cardiology services. However, these were offset by significant challenges in Mexico, including a decline in revenue and difficulties in system integration, as well as ongoing political and economic challenges in Colombia.
Q3-2025 Updates
Positive Updates
Strong Performance in Peru and Colombia
Peru's revenue grew by 9% and adjusted EBITDA increased by 15%, with a margin increase of 1.1 percentage points to 22.7%. Colombia's revenue grew by 5%, and adjusted EBITDA increased by 18% with a margin expansion of 1.7 percentage points.
Successful Debt Refinancing
Auna completed a $765 million debt refinancing, extending maturities, reducing financing costs, and enhancing liquidity. This included $365 million of senior secured notes and a $400 million equivalent term loan in Mexican pesos, saving 125 basis points in interest rates.
Growth in Oncology and Cardiology Services in Mexico
Oncology and cardiology services in Mexico increased 48% versus the second quarter of 2025, accounting for 15% of Mexico's revenues. Revenues from Opción Oncología increased by 21% over the previous quarter.
Strategic Partnership with Sojitz
Auna announced a Memorandum of Understanding with Sojitz Corporation of America to accelerate growth in Mexico, aiming to leverage Sojitz's expertise and resources.
Expansion Plans in Mexico
Auna plans to increase out-of-pocket revenue in Mexico from 8% to 20% by the end of next year, with a 15% increase in the third quarter. The company is also working on expanding its payer network and rolling out new service packages.
Negative Updates
Decline in Revenue and EBITDA in Mexico
Mexico's revenue decreased by 12%, and total adjusted EBITDA declined by 5% due to slower-than-expected recovery in volumes, issues with doctor-supplier relationships, and problems with new ERP system implementation.
Capacity Utilization Challenges
Capacity utilization decreased by 3 percentage points to 64%, with Mexico experiencing a 4.4 percentage point decrease year-over-year due to decreased surgery volumes and emergency visits.
Impact of System Integration in Mexico
The migration to new information and ERP systems at Doctors Hospital in Mexico affected billings and resulted in delayed accounts receivable.
Political and Economic Challenges in Colombia
The political environment in Colombia is expected to remain challenging, impacting the flow of payments and potentially delaying improvements in the health care sector.
Company Guidance
During the third quarter of 2025, Auna reported a 5% year-over-year decline in total adjusted EBITDA, primarily due to weaker performance in its Mexican operations. Despite this, Peru and Colombia showed robust financial results, with Peru's local currency top line growing 9% and Colombia's by 4%. Capacity utilization across the company fell by 3 percentage points to 64%. In Mexico, the quarter was marked by slower recovery from legacy doctor volumes and challenges with implementing new hospital information systems. However, surgery volumes increased for the second consecutive quarter, and oncology and cardiology services grew by 48%. The company reported adjusted net income of PEN 58 million and maintained an unchanged leverage ratio due to reduced gross debt. Auna anticipates a full recovery in Mexico by 2026, supported by a new leadership team and strategic partnerships, such as the collaboration with Sojitz Corporation, to accelerate growth while maintaining a target leverage ratio below 3x.

Auna S.A. Class A Financial Statement Overview

Summary
Auna S.A. Class A demonstrates strengths in operational efficiency and cash flow generation. However, the company faces challenges with declining revenue growth and high leverage. The financial health is stable but requires attention to improve profitability and reduce financial risk.
Income Statement
65
Positive
Auna S.A. Class A shows a mixed performance in its income statement. The company has a strong gross profit margin of 38.68% in TTM, indicating efficient cost management. However, the net profit margin is relatively low at 4.34%, suggesting challenges in converting revenue into profit. The revenue growth rate has declined by 22.5% in TTM, which is a concern. EBIT and EBITDA margins are healthy, reflecting good operational efficiency.
Balance Sheet
58
Neutral
The balance sheet reveals a high debt-to-equity ratio of 2.23 in TTM, indicating significant leverage and potential financial risk. Return on equity is moderate at 11.91%, showing reasonable profitability for shareholders. The equity ratio stands at 22.76%, suggesting a balanced asset structure but with room for improvement in reducing debt levels.
Cash Flow
70
Positive
Cash flow analysis shows a positive trend with a free cash flow growth rate of 51.3% in TTM, indicating strong cash generation capabilities. The operating cash flow to net income ratio is 0.31, and the free cash flow to net income ratio is 0.79, both reflecting efficient cash conversion from earnings. Overall, cash flow management appears robust.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue4.22B4.40B3.85B2.44B1.97B1.49B
Gross Profit1.63B1.64B1.33B836.88M682.26M527.74M
EBITDA1.00B928.12M723.50M301.35M175.09M115.44M
Net Income182.50M110.72M-252.04M-85.24M-27.09M-7.32M
Balance Sheet
Total Assets7.28B7.08B7.69B6.59B2.82B2.65B
Cash, Cash Equivalents and Short-Term Investments325.40M335.97M334.26M208.69M138.77M343.45M
Total Debt3.70B3.77B3.92B3.51B1.49B1.35B
Total Liabilities5.47B5.46B5.91B5.04B2.28B2.00B
Stockholders Equity1.66B1.48B1.47B1.06B495.82M600.93M
Cash Flow
Free Cash Flow499.74M577.64M417.25M10.67M-106.03M27.38M
Operating Cash Flow633.32M668.50M582.41M162.64M183.34M156.30M
Investing Cash Flow-183.01M-236.82M-173.15M-3.21B-291.99M-125.93M
Financing Cash Flow-426.35M-418.12M-370.00M3.13B-102.13M272.70M

Auna S.A. Class A Technical Analysis

Technical Analysis Sentiment
Positive
Last Price4.99
Price Trends
50DMA
4.85
Positive
100DMA
5.27
Negative
200DMA
5.84
Negative
Market Momentum
MACD
0.04
Negative
RSI
55.69
Neutral
STOCH
84.02
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AUNA, the sentiment is Positive. The current price of 4.99 is above the 20-day moving average (MA) of 4.95, above the 50-day MA of 4.85, and below the 200-day MA of 5.84, indicating a neutral trend. The MACD of 0.04 indicates Negative momentum. The RSI at 55.69 is Neutral, neither overbought nor oversold. The STOCH value of 84.02 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AUNA.

Auna S.A. Class A Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
$747.11M99.566.65%18.37%
60
Neutral
$483.80M0.930.74%
58
Neutral
$380.43M7.4011.61%2.14%
54
Neutral
$657.50M-12.23-44.33%34.99%-68.73%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
48
Neutral
$286.32M-18.10-3.76%-22.14%-787.87%
46
Neutral
$107.70M-5.80-21.85%-16.54%-119.56%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AUNA
Auna S.A. Class A
5.14
-3.02
-37.01%
SNDA
Sonida Senior Living
35.03
10.04
40.18%
CYH
Community Health
3.49
-0.43
-10.97%
CCRN
Cross Country Healthcare
8.74
-8.50
-49.30%
TALK
Talkspace
4.51
1.57
53.40%
AIRS
Airsculpt Technologies
1.73
-2.95
-63.14%

Auna S.A. Class A Corporate Events

Auna S.A. Reports Mixed 3Q25 Results Amid Regional Challenges
Nov 20, 2025

On November 20, 2025, Auna S.A. announced its financial results for the third quarter of 2025, highlighting a mixed performance across its operations in Peru, Colombia, and Mexico. While the company saw growth in Peru and Colombia, with increased revenues and profitability in local currencies, Mexico faced challenges with declining revenues and profitability due to legacy issues and system migrations. Despite these challenges, Auna maintained a stable leverage ratio and completed a significant debt refinancing, positioning itself for future growth and operational improvements.

The most recent analyst rating on (AUNA) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Auna S.A. Class A stock, see the AUNA Stock Forecast page.

Auna S.A. Partners with Sojitz to Boost Healthcare in Latin America
Nov 20, 2025

On November 20, 2025, Auna S.A. announced a strategic collaboration with Sojitz Corporation of America to explore joint business opportunities in the healthcare sector across Latin America, initially focusing on Mexico. This partnership aims to leverage Auna’s healthcare expertise and Sojitz’s investment capabilities to develop scalable and accessible healthcare infrastructure in the region. Previously, on September 24, 2025, Auna declared its intention to invest approximately $500 million over the next three to five years to expand its healthcare platform in Mexico, marking a significant step in its strategy to enhance healthcare access in Latin America.

The most recent analyst rating on (AUNA) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Auna S.A. Class A stock, see the AUNA Stock Forecast page.

Auna S.A. Completes $765 Million Debt Refinancing to Boost Growth
Nov 7, 2025

On November 7, 2025, Auna S.A. announced the completion of a US$765 million debt refinancing, which strengthens its capital structure by extending debt maturities, reducing interest expenses, and enhancing liquidity. This refinancing involved issuing new Senior Secured 2032 Notes and a Term Loan, with significant participation from the International Finance Corporation. The transaction is expected to improve Auna’s financial position, aiding its strategic growth initiatives and expanding healthcare access in Latin America.

The most recent analyst rating on (AUNA) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Auna S.A. Class A stock, see the AUNA Stock Forecast page.

Auna S.A. Successfully Prices $365M Senior Secured Notes
Nov 4, 2025

On November 4, 2025, Auna S.A. announced the successful pricing of $365 million in 8.750% Senior Secured Notes due 2032. The issuance, co-led with Oncosalud S.A.C., aims to fund a tender offer for its existing 10.000% Senior Secured Notes due 2029 and to prepay certain debts. This strategic financial move is expected to optimize Auna’s capital structure and enhance its financial flexibility, potentially strengthening its position in the Latin American healthcare market.

The most recent analyst rating on (AUNA) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Auna S.A. Class A stock, see the AUNA Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 23, 2025